Invention Grant
US08658700B2 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
有权
用反式4-（3,4-二氯苯基）-1,2,3,4-四氢-1-萘胺处理CNS病症
- Patent Title: Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
- Patent Title (中): 用反式4-（3,4-二氯苯基）-1,2,3,4-四氢-1-萘胺处理CNS病症
-
Application No.: US13693489Application Date: 2012-12-04
-
Publication No.: US08658700B2Publication Date: 2014-02-25
- Inventor: Thomas Jerussi , Qun Kevin Fang , Mark G. Currie
- Applicant: Sunovion Pharmaceuticals Inc.
- Applicant Address: US MA Marlborough
- Assignee: Sunovion Pharmaceuticals Inc.
- Current Assignee: Sunovion Pharmaceuticals Inc.
- Current Assignee Address: US MA Marlborough
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Main IPC: A61K31/135
- IPC: A61K31/135 ; C07C211/42
Abstract:
Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is also disclosed. The process includes the preparation of all four isomers of N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide, which are also useful.
Public/Granted literature
- US20130158125A1 Treatment of CNS Disorders with trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine Public/Granted day:2013-06-20
Information query
